 Kaplan-Meier Estimate
"Kaplan-Meier Estimate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
| Descriptor ID |
D053208
|
| MeSH Number(s) |
E05.318.740.998.650 N05.715.360.750.795.650 N06.850.520.830.998.650
|
| Concept/Terms |
Kaplan-Meier Estimate- Kaplan-Meier Estimate
- Estimate, Kaplan-Meier
- Kaplan-Meier Test
- Kaplan Meier Test
- Test, Kaplan-Meier
- Product-Limit Method
- Method, Product-Limit
- Methods, Product-Limit
- Product Limit Method
- Product-Limit Methods
- Kaplan-Meier Analysis
- Analysis, Kaplan-Meier
- Kaplan Meier Analysis
Kaplan-Meier Survival Curves- Kaplan-Meier Survival Curves
- Curves, Kaplan-Meier Survival
- Kaplan Meier Survival Curves
- Survival Curves, Kaplan-Meier
|
Below are MeSH descriptors whose meaning is more general than "Kaplan-Meier Estimate".
Below are MeSH descriptors whose meaning is more specific than "Kaplan-Meier Estimate".
This graph shows the total number of publications written about "Kaplan-Meier Estimate" by people in this website by year, and whether "Kaplan-Meier Estimate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 3 | 3 | | 2007 | 0 | 15 | 15 | | 2008 | 0 | 23 | 23 | | 2009 | 0 | 47 | 47 | | 2010 | 0 | 38 | 38 | | 2011 | 0 | 56 | 56 | | 2012 | 0 | 64 | 64 | | 2013 | 1 | 43 | 44 | | 2014 | 1 | 55 | 56 | | 2015 | 0 | 52 | 52 | | 2016 | 0 | 43 | 43 | | 2017 | 0 | 66 | 66 | | 2018 | 0 | 40 | 40 | | 2019 | 0 | 35 | 35 | | 2020 | 0 | 16 | 16 | | 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Kaplan-Meier Estimate" by people in Profiles.
-
Berger Y, Giurcanu M, Vining CC, Schuitevoerder D, Posner MC, Roggin KK, Polite BN, Liao CY, Eng OS, Catenacci DVT, Turaga KK. Cytoreductive Surgery for Selected Patients Whose Metastatic Gastric Cancer was Treated with Systemic Chemotherapy. Ann Surg Oncol. 2021 Aug; 28(8):4433-4443.
-
Derman BA, Langerman SS, Maric M, Jakubowiak A, Zhang W, Chiu BC. Sex differences in outcomes in multiple myeloma. Br J Haematol. 2021 02; 192(3):e66-e69.
-
Rooney MK, Korpics MC, Turchan WT, Callahan N, Koshy M, Spiotto MT. Patterns of Care and Survival Outcomes for Odontogenic Cancers. Laryngoscope. 2021 05; 131(5):E1496-E1502.
-
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW. Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia. N Engl J Med. 2020 08 13; 383(7):617-629.
-
DeAngelo DJ, Advani AS, Marks DI, Stelljes M, Liedtke M, Stock W, Gökbuget N, Jabbour E, Merchant A, Wang T, Vandendries E, Neuhof A, Kantarjian H, O'Brien S. Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden. Blood Cancer J. 2020 08 07; 10(8):81.
-
Derman BA, Jasielec J, Langerman SS, Zhang W, Jakubowiak AJ, Chiu BC. Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis. Blood Cancer J. 2020 08 07; 10(8):80.
-
Garcia-Manero G, Griffiths EA, Steensma DP, Roboz GJ, Wells R, McCloskey J, Odenike O, DeZern AE, Yee K, Busque L, O'Connell C, Michaelis LC, Brandwein J, Kantarjian H, Oganesian A, Azab M, Savona MR. Oral cedazuridine/decitabine for MDS and CMML: a phase 2 pharmacokinetic/pharmacodynamic randomized crossover study. Blood. 2020 08 06; 136(6):674-683.
-
Bortz MD, Kuchta K, Winchester DJ, Prinz RA, Moo-Young TA. Extrathyroidal extension predicts negative clinical outcomes in papillary thyroid cancer. Surgery. 2021 Jan; 169(1):2-6.
-
Schöder H, Polley MC, Knopp MV, Hall N, Kostakoglu L, Zhang J, Higley HR, Kelloff G, Liu H, Zelenetz AD, Cheson BD, Wagner-Johnston N, Kahl BS, Friedberg JW, Hsi ED, Leonard JP, Schwartz LH, Wilson WH, Bartlett NL. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 2020 06 18; 135(25):2224-2234.
-
Di Bartolomeo M, Raimondi A, Cecchi F, Catenacci DVT, Schwartz S, Sellappan S, Tian Y, Miceli R, Pellegrinelli A, Giommoni E, Aitini E, Spada F, Rosati G, Marchet A, Pucci F, Zaniboni A, Tamberi S, Pressiani T, Sanna G, Cantore M, Mosconi S, Bolzoni P, Pinto C, Landi L, Soto Parra HJ, Cavanna L, Corallo S, Martinetti A, Hembrough TA, Pietrantonio F. Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S. Tumori. 2021 Apr; 107(2):150-159.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|